Results 261 to 270 of about 259,065 (325)
Aborted Sudden Cardiac Death Due to Acquired QT Prolongation: A Case Report. [PDF]
Aletras G+4 more
europepmc +1 more source
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen+3 more
wiley +1 more source
Prevalence Characteristics and Spatial Aggregation of Sudden Cardiac Death in Shandong Province by Counties and Districts, 2020 to 2021. [PDF]
Zhou Y+7 more
europepmc +1 more source
Abstract Background and Purpose Treatment of cancer patients with anthracyclines is known to cause dose‐dependent cardiotoxicity through several mechanisms including enhanced oxidative stress, ultimately resulting in defective excitation–contraction coupling.
Wesam Bassiouni+9 more
wiley +1 more source
Unmasking a killer: Brugada ECG pattern in cannabis users - A warning sign for sudden cardiac death.
Manasa M.
europepmc +1 more source
Sudden cardiac death in pulmonary arterial hypertension. [PDF]
Drakopoulou M+3 more
europepmc +1 more source
Organoid Models to Study Human Infectious Diseases
Our manuscript reviews the role of organoids as models for studying human infectious diseases, highlighting their irreplaceable contributions to drug testing and vaccine development for significant infectious diseases including HIV, ZIKV, SARS‐CoV‐2 and MPXV.
Sijing Zhu+4 more
wiley +1 more source
Role of the wearable cardioverter defibrillator in the initial period of sudden cardiac death risk stratification: results of a European Heart Rhythm Association survey. [PDF]
Migliore F+10 more
europepmc +1 more source